Amyotrophic lateral sclerosis is a neurodegenerative disease predominantly affecting upper
and lower motor neurons, resulting in progressive paralysis and death from respiratory …

Background Riluzole is the only drug to prolong survival for amyotrophic lateral sclerosis (ALS)
and, at a dose of 100 mg, was associated with a 35% reduction in mortality in a clinical …

Characterizing genetic influences on DNA methylation (DNAm) provides an opportunity to
understand mechanisms underpinning gene regulation and disease. In the present study, we …

Progress in dementia research has been limited, with substantial gaps in our knowledge of
targets for prevention, mechanisms for disease progression, and disease-modifying …

Identifying large expansions of short tandem repeats (STRs), such as those that cause
amyotrophic lateral sclerosis (ALS) and fragile X syndrome, is challenging for short-read whole-…

Increased cerebrospinal fluid neurofilament light (NfL) is a recognized biomarker for
neurodegeneration that can also be assessed in blood. Here, we investigate plasma NfL as a …

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with a lifetime risk
of one in 350 people and an unmet need for disease-modifying therapies. We conducted a …

Amyotrophic lateral sclerosis and Parkinson’s disease are neurodegenerative diseases of
the motor system which are now recognized also to affect non-motor pathways. Non-motor …

The expansion of a hexanucleotide repeat GGGGCC in C9orf72 is the most common known
cause of ALS accounting for ~ 40% familial cases and ~ 7% sporadic cases in the European …

There is a strong genetic contribution to Amyotrophic lateral sclerosis (ALS) risk, with heritability
estimates of up to 60%. Both Mendelian and small effect variants have been identified, …